Molecular profile of gastric cancer as a basis of individualized treatment and prognosis of disease outcome

Exp Oncol. 2011 Sep;33(3):182-5.

Authors

D V Demash¹, V M Bazas, N Yu Lukianova, D O Rozumiy, V F Chekhun

Affiliation

¹ R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine. [email protected]

PMID: 21956476

No abstract available

MeSH terms

Antibodies, Monoclonal / immunology
Biomarkers, Tumor / analysis*
Cadherins / analysis
Catenins / analysis
Humans
Molecular Diagnostic Techniques
Precision Medicine / methods*
Prognosis
Proto-Oncogene Proteins c-bcl-2 / analysis
Proto-Oncogene Proteins c-bcl-2 / immunology
Receptor, ErbB-2 / analysis
Stomach Neoplasms / genetics
Stomach Neoplasms / metabolism*
Stomach Neoplasms / mortality
Stomach Neoplasms / therapy*
Tumor Suppressor Protein p53 / analysis
Vascular Endothelial Growth Factor A / analysis
Vascular Endothelial Growth Factor A / biosynthesis

Substances

Antibodies, Monoclonal
Biomarkers, Tumor
Cadherins
Catenins
Proto-Oncogene Proteins c-bcl-2
Tumor Suppressor Protein p53
Vascular Endothelial Growth Factor A
Receptor, ErbB-2